Novel coronavirus vaccine is being developed by global scientists with the support of CEPI.

The novel coronavirus has killed more than 800 people and infected more than 37000 people in China, and 24 countries reported cases in February 9th The development of any vaccine usually takes several years, involving the long process of testing animals, conducting clinical trials in humans and obtaining regulatory approval However, with the support of the Innovation Alliance for epidemic prevention (CEPI), several teams of experts are competing to speed up the development, and Australian scientists hope that their vaccine can be developed successfully within six months CEPI was founded in 2017 to fund expensive biotechnology research after the Ebola outbreak in West Africa killed more than 11000 people With the mission of accelerating vaccine development, CEPI has invested millions of dollars in four projects around the world and issued a call for more proposals Richard Hatchett, CEO of CEPI, said its goal is to start clinical trials within 16 weeks These projects hope to use new technologies to develop vaccines that can be tested in the near future Curevac, a German biopharmaceutical company, and Moderna therapeutics in the United States are developing vaccines based on "messenger RNA", while inobio, another American company, uses DNA based technology In response, the researchers explained that DNA and RNA based vaccines use the genetic code of the virus to "trick" human cells into producing the same proteins as the surface of pathogens, and the immune system learns to recognize these proteins in order to detect and attack the virus when it enters the human body Australian researchers are using "molecular tweezers" technology to enable them to quickly develop new vaccines based only on viral DNA sequences Scientists at the Pasteur Institute in France are improving the measles vaccine against the coronavirus, but it is not expected to be developed successfully within 20 months Meanwhile, China's centers for Disease Control and prevention began to develop vaccines, Xinhua reported The risks and benefits of approving a vaccine are weighed by health authorities, which can shorten the process in the event of a public health emergency But if things improve, the vaccine development process will be longer Although there is no vaccine for the coronavirus, some doctors are trying to use effective antiretroviral and influenza drugs to treat infected people In the end, scientists may encounter the same situation as when SARS broke out in 2002-2003, which disappeared before the vaccine was fully developed But ong Siew Hwa, head of acumen research laboratories, a biotechnology company in Singapore, said that efforts should continue to be made to develop a vaccine against the new virus even after the outbreak ended Reference: [1] Scientists race to develop vaccine for new coronavirus